CM/PHR/22/5686- NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer
Estimated value
—
goods
Awarded value
—
Suppliers
6
1 SME
Lots
1
6 awarded
Published
03 Apr 2024
Description
Proposed NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)<br/>Tender Reference: CM/PHR/22/5686/01<br/> <br/>Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).
Scope
- Reference
- CM/PHR/22/5686
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2024 to 31 Mar 2028
- Main category
- goods
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 6 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—